Orthofuse
A medtech startup developing 'tweakable' 3D-printed titanium implants that allow surgeons to perform intraoperative customization for spinal and orthopedic procedures.
- CEO / Founder
- James Scott
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- £2.2M
- Latest Round
- Seed
- Key Investors
- ACF Investors, Cambridge Angels, Empirical Ventures
Technology & Products
Key Products
3D-printed implant systems with re-positionable architectures for trauma and spinal surgery, allowing intraoperative customization.
Technological Advantage
Combines the precision of additive manufacturing with mechanical adjustability, bridging the gap between generic off-the-shelf implants and expensive, slow-to-produce patient-specific custom devices.
Differentiation
Value Proposition
Reduces the need for large inventories of pre-sized implants by providing a 'tweakable' solution that can be adjusted in real-time to fit a patient's unique anatomy, improving surgical precision and patient outcomes in complex cases.
How They Differentiate
Unlike static 3D-printed implants or pre-planned patient-specific devices, Orthofuse offers 'tweakable' intraoperative customization, allowing surgeons to adjust the implant's mechanical properties in real-time during surgery.
Market & Competition
Target Customers
Spinal and orthopedic surgeons, hospitals, and specialized surgical centers.
Industry Verticals
["Medical Devices","Orthopedics","Spinal Surgery","Additive Manufacturing (3D Printing)"]
Competitors
Materialise NV, 3D Systems, Stratasys, Osseus Fusion Systems, Nexxt Spine
Growth & Milestones
Growth Metrics
Transitioning from technical development to regulatory readiness and early-stage clinical evaluations.
Major Milestones
["Company founded in 2022 by James Scott and Julian Leong","Secured £2.2M Seed funding in February 2024","Development of proprietary 'tweakable' titanium lattice structure technology","Established clinical research ties with the Royal National Orthopaedic Hospital (RNOH)"]
Notable Customers
Royal National Orthopaedic Hospital (Clinical Partner)